Brendan Teehan, EVP, COO, Head of Commercial at ACADIA PHARMACEUTICALS INC (ACAD), sold 9,920 shares at $22.64 ($225K) on 2023-11-20, disclosed to the SEC on 2023-11-21.
Open-market sale of $225k ACAD by EVP, COO, Head of Commercial. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.64 | 4,960 | $112K | 50.0% |
| 2 | $22.64 | 4,960 | $112K | 50.0% |
| Total | $22.64 avg | 9,920 | $225K | 100% |
| Filing → |
| ACAD | SELL | 2024-05-03 | $118K | — | Filing → |
| ACAD | SELL | 2024-04-09 | $46K | — | Filing → |
| ACAD | SELL | 2024-03-27 | $184K | — | Filing → |